CE2023-02-14T18:05:28
The global highly potent active pharmaceutical ingredient (HPAPI) market is expected to reach $34.04 billion in 2026, a report has predicted.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-10T09:30:00Z
Sponsored by Capsugel
2026-10-27T10:14:00Z
Sponsored by Capsugel
2026-10-22T10:54:00Z
2026-10-21T11:35:00Z
2026-06-29T06:00:00
Sponsored by Lubrizol Advanced Materials Europe BV
2026-09-03T15:04:00
Sponsored by Octave, Adam Cross
2026-04-29T14:00:00
Sponsored by USP
2026-05-22T14:48:00
Sponsored by CPhI
Site powered by Webvision Cloud